Versantis ranked in the Top5 best Swiss startups #top100ssu.
Very proud of our team and achievements. Next milestone towards a first-line treatment for acute liver decompensation: completing VS-01 Phase 1b clinical trial.
Versantis selected by innovation analysts from StartUS Insights as a Top 5 Orphan Drug Startup company impacting the Pharma Industry today.
Exciting independent recognition as over 230 companies were analyzed worldwide. The Global Startup Heat Map below highlights the selected 5 startups & emerging companies developing orphan drug solutions. Congratulation to all, our efforts to help underserved patients is being recognized.
For the 5th consecutive year, Versantis reaches top Swiss Startups and scores #2 BEST BIOTECH!
This repeated selection among the TOP is an honor and continuous recognition for our team. Congratulation to all the other teams and see you again next year!
Versantis meets its target and reaches the TOP-10 best Swiss startups, after 3 sequential years elected among the best 100.
We are very proud to reach this strong group of best young and promising Swiss companies. Thanks to the organizers VentureLab and big thanks to our amazing team! What an honor!
Versantis elected in the TOP-100 best Swiss startups and ranked the #1 BEST BIOTECH STARTUP!
Ranked at the 11th position, Versantis is proud to be amount the best innovators of Switzerland. Even better, Versantis was the best startup in the category Biotechnology.
Next year target: top 10!
Versantis won the MassChallenge 2016 ! The team is thrilled and honored it has had a chance to work with inspiring mentors and coaches throughout the 4 months of the accelerator program. We will continue to build on the strong milestones we’ve achieved and grow our Company with even more passion.
We are very proud to belong to the first cohort of MassChallenge Switzerland and to be part of the global MassChallenge community. A special thanks to the MassChallenge team in Switzerland, Juliette, Satu, Ka, Carmello, Benoît…you guys rock!
Read further press coverage:
Versantis is very proud to be selected in the final round of MassChallenge Switzerland. With over 4'200 applicants worldwide and +450 in Switzerland, it is an honor to be among the TOP13.
"We are very proud of the achievements of all of the start-ups in our cohort. We believe that the final 13 have the potential to become number one in their fields and are on the cusp of major successes.” - Mass Challenge Swizterland founding partner.
Versantis wins a Cydan scholarship!
We are proud to announce that Cydan Development, a sponsor of the prestigious MassChallenge accelerator, has awarded one of its five MassChallenge scholarships to Versantis. Read Cydan's announcement here.
Versantis is finalist of the MASS Challenge Switzerland!
Versantis awarded with CTI Start-up Label, a seal of quality and maturity.
Versantis made it to the final round of the Pioneers Asia Challenge.
Congratulations to V. Forster, Winner of the Pfizer Research Award
Versantis receives 20’000 £ as a finalist of the Wellcome Translation Award
Versantis wins the CHF 100'000.- prize of Venture Kick Stage 3
Versantis wins the pitching competition at the 2014 CEO day in Berne
Versantis is a finalist of the 2014 Swiss Technology Award in the category Inventors
Versantis wins the CHF 20'000.- prize of Venture Kick Stage 1, an entry door to the final stage of the competition.
Versantis wins the 2014 >>Venture>> TOP10 business plan competition
Versantis participates in Venture Leaders 2014
Versantis is finalist of the 2014 Innovact Creation Award!
Versantis wins the TOP 10 >>venture>> Business Idea Award!